Media Releases

23 August 2017: Upside appoints leading US life sciences executive to Board

23 May 2017: Upside Biotechnologies signs R&D agreement with US Army

22 March 2017: Upside Biotechnologies raises $2.3m in Series A funding round

20 February 2017: David Flacks chairs Upside Biotechnologies

15 November 2016: Skin is the game for regenerative medicine spinoff